P3 Health Partners [PIII] vs Acadia Healthcare [ACHC] Detailed Stock Comparison

P3 Health Partners
NASDAQ
Loading...

Acadia Healthcare
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: P3 Health Partners wins in 8 metrics, Acadia Healthcare wins in 9 metrics, with 0 ties. Acadia Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | P3 Health Partners | Acadia Healthcare | Better |
---|---|---|---|
P/E Ratio (TTM) | -0.15 | 13.80 | P3 Health Partners |
Price-to-Book Ratio | 0.53 | 0.62 | P3 Health Partners |
Debt-to-Equity Ratio | 221.06 | 74.74 | Acadia Healthcare |
PEG Ratio | 0.00 | -0.22 | Acadia Healthcare |
EV/EBITDA | -0.95 | 6.76 | P3 Health Partners |
Profit Margin (TTM) | -9.99% | 4.31% | Acadia Healthcare |
Operating Margin (TTM) | -9.59% | 16.37% | Acadia Healthcare |
EBITDA Margin (TTM) | N/A | 16.37% | N/A |
Return on Equity | -141.55% | 4.83% | Acadia Healthcare |
Return on Assets (TTM) | -24.31% | 4.92% | Acadia Healthcare |
Free Cash Flow (TTM) | $-110.13M | $-560.69M | P3 Health Partners |
1-Year Return | -70.58% | -73.19% | P3 Health Partners |
Price-to-Sales Ratio (TTM) | 1.00 | 0.60 | Acadia Healthcare |
Enterprise Value | $219.57M | $4.36B | Acadia Healthcare |
EV/Revenue Ratio | 0.15 | 1.35 | P3 Health Partners |
Gross Profit Margin (TTM) | N/A | 96.72% | N/A |
Revenue per Share (TTM) | $449 | $35 | P3 Health Partners |
Earnings per Share (Diluted) | $-51.33 | $1.52 | Acadia Healthcare |
Beta (Stock Volatility) | 0.80 | 0.88 | P3 Health Partners |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
P3 Health Partners vs Acadia Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
P3 Health Partners | -0.07% | 5.33% | 9.92% | -6.40% | -29.71% | -41.52% |
Acadia Healthcare | 0.56% | 3.68% | -1.02% | -8.89% | -45.98% | -47.46% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
P3 Health Partners | -70.58% | -96.88% | -98.50% | -98.50% | -98.50% | -98.50% |
Acadia Healthcare | -73.19% | -74.08% | -31.41% | -71.29% | 353.81% | 114.20% |
Performance & Financial Health Analysis: P3 Health Partners vs Acadia Healthcare
Metric | PIII | ACHC |
---|---|---|
Market Information | ||
Market Cap | $1.46B | $1.94B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 4,156 | 3,251,860 |
90 Day Avg. Volume | 9,609 | 2,130,137 |
Last Close | $7.31 | $21.42 |
52 Week Range | $5.80 - $29.20 | $17.13 - $82.41 |
% from 52W High | -74.97% | -74.01% |
All-Time High | $16.73 (Dec 06, 2021) | $89.85 (Nov 28, 2022) |
% from All-Time High | -56.31% | -76.16% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.06% | 0.09% |
Quarterly Earnings Growth | -0.06% | -0.62% |
Financial Health | ||
Profit Margin (TTM) | -0.10% | 0.04% |
Operating Margin (TTM) | -0.10% | 0.16% |
Return on Equity (TTM) | -1.42% | 0.05% |
Debt to Equity (MRQ) | 221.06 | 74.74 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $13.60 | $34.05 |
Cash per Share (MRQ) | $11.81 | $1.42 |
Operating Cash Flow (TTM) | $-129,955,000 | $424.81M |
Levered Free Cash Flow (TTM) | $-1,812,750 | $-267,134,000 |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: P3 Health Partners vs Acadia Healthcare
Metric | PIII | ACHC |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | -0.15 | 13.80 |
Forward P/E | -34.14 | 5.72 |
PEG Ratio | 0.00 | -0.22 |
Price to Sales (TTM) | 1.00 | 0.60 |
Price to Book (MRQ) | 0.53 | 0.62 |
Market Capitalization | ||
Market Capitalization | $1.46B | $1.94B |
Enterprise Value | $219.57M | $4.36B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 0.15 | 1.35 |
Enterprise to EBITDA | -0.95 | 6.76 |
Risk & Other Metrics | ||
Beta | 0.80 | 0.88 |
Book Value per Share (MRQ) | $13.60 | $34.05 |
Financial Statements Comparison: P3 Health Partners vs Acadia Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | PIII | ACHC |
---|---|---|
Revenue/Sales | $373.23M | $770.51M |
Cost of Goods Sold | N/A | $28.34M |
Gross Profit | N/A | $742.16M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | $-38.09M | $78.50M |
EBITDA | $-16.72M | $125.53M |
Pre-Tax Income | $-43.17M | $13.47M |
Income Tax | $1.07M | $4.40M |
Net Income (Profit) | $-44.25M | $9.06M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | PIII | ACHC |
---|---|---|
Cash & Equivalents | $40.08M | $91.24M |
Total Current Assets | $191.44M | $638.95M |
Total Current Liabilities | $507.03M | $473.35M |
Long-Term Debt | $117.10M | $2.29B |
Total Shareholders Equity | $121.08M | $3.17B |
Retained Earnings | $-523.67M | $348.45M |
Property, Plant & Equipment | $1.08M | $597.87M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | PIII | ACHC |
---|---|---|
Operating Cash Flow | $-43.46M | $30.01M |
Capital Expenditures | N/A | $43,000 |
Free Cash Flow | $-33.47M | $-163.15M |
Debt Repayment | $-341,000 | $-1.71B |
Common Stock Repurchase | N/A | $-46.88M |
Short Interest & Institutional Ownership Analysis
Metric | PIII | ACHC |
---|---|---|
Shares Short | 35,245 | 10.54M |
Short Ratio | 3.21 | 6.05 |
Short % of Float | 0.10% | 0.14% |
Average Daily Volume (10 Day) | 4,156 | 3,251,860 |
Average Daily Volume (90 Day) | 9,609 | 2,130,137 |
Shares Outstanding | 3.26M | 91.78M |
Float Shares | 1.23M | 90.63M |
% Held by Insiders | 0.62% | 0.02% |
% Held by Institutions | 0.11% | 1.16% |
Dividend Analysis & Yield Comparison: P3 Health Partners vs Acadia Healthcare
Metric | PIII | ACHC |
---|---|---|
Last 12-Month Dividend | N/A | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | N/A |
Ex-Dividend Date | N/A | N/A |